| Product Code: ETC9491753 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Sudan Hemophilia B Market Overview |
3.1 Sudan Country Macro Economic Indicators |
3.2 Sudan Hemophilia B Market Revenues & Volume, 2021 & 2031F |
3.3 Sudan Hemophilia B Market - Industry Life Cycle |
3.4 Sudan Hemophilia B Market - Porter's Five Forces |
3.5 Sudan Hemophilia B Market Revenues & Volume Share, By Drugs, 2021 & 2031F |
3.6 Sudan Hemophilia B Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.7 Sudan Hemophilia B Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Sudan Hemophilia B Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.9 Sudan Hemophilia B Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Sudan Hemophilia B Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about hemophilia B and its treatment options in Sudan |
4.2.2 Growing investments in healthcare infrastructure and facilities in Sudan |
4.2.3 Rising prevalence of hemophilia B cases in Sudan |
4.3 Market Restraints |
4.3.1 Limited access to advanced treatment options and medications in Sudan |
4.3.2 High cost associated with hemophilia B treatment and management |
4.3.3 Lack of skilled healthcare professionals specialized in hemophilia B care in Sudan |
5 Sudan Hemophilia B Market Trends |
6 Sudan Hemophilia B Market, By Types |
6.1 Sudan Hemophilia B Market, By Drugs |
6.1.1 Overview and Analysis |
6.1.2 Sudan Hemophilia B Market Revenues & Volume, By Drugs, 2021- 2031F |
6.1.3 Sudan Hemophilia B Market Revenues & Volume, By Plasma Derived Coagulation Factor Concentrate, 2021- 2031F |
6.1.4 Sudan Hemophilia B Market Revenues & Volume, By Recombinant Coagulation Factor Concentrates, 2021- 2031F |
6.1.5 Sudan Hemophilia B Market Revenues & Volume, By Desmopressin, 2021- 2031F |
6.1.6 Sudan Hemophilia B Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Sudan Hemophilia B Market, By Treatment |
6.2.1 Overview and Analysis |
6.2.2 Sudan Hemophilia B Market Revenues & Volume, By On-Demand, 2021- 2031F |
6.2.3 Sudan Hemophilia B Market Revenues & Volume, By Prophylaxis, 2021- 2031F |
6.3 Sudan Hemophilia B Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Sudan Hemophilia B Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 Sudan Hemophilia B Market Revenues & Volume, By Injectable, 2021- 2031F |
6.4 Sudan Hemophilia B Market, By End-Users |
6.4.1 Overview and Analysis |
6.4.2 Sudan Hemophilia B Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Sudan Hemophilia B Market Revenues & Volume, By Homecare, 2021- 2031F |
6.4.4 Sudan Hemophilia B Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.4.5 Sudan Hemophilia B Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Sudan Hemophilia B Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Sudan Hemophilia B Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.5.3 Sudan Hemophilia B Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.5.4 Sudan Hemophilia B Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
7 Sudan Hemophilia B Market Import-Export Trade Statistics |
7.1 Sudan Hemophilia B Market Export to Major Countries |
7.2 Sudan Hemophilia B Market Imports from Major Countries |
8 Sudan Hemophilia B Market Key Performance Indicators |
8.1 Number of hemophilia B awareness campaigns conducted in Sudan |
8.2 Percentage increase in healthcare expenditure towards hemophilia B treatment in Sudan |
8.3 Number of hemophilia B treatment centers established in Sudan |
9 Sudan Hemophilia B Market - Opportunity Assessment |
9.1 Sudan Hemophilia B Market Opportunity Assessment, By Drugs, 2021 & 2031F |
9.2 Sudan Hemophilia B Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.3 Sudan Hemophilia B Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Sudan Hemophilia B Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.5 Sudan Hemophilia B Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Sudan Hemophilia B Market - Competitive Landscape |
10.1 Sudan Hemophilia B Market Revenue Share, By Companies, 2024 |
10.2 Sudan Hemophilia B Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here